| DC Field | Value | Language |
|---|
| dc.contributor.author | Kanishk, Dang | - |
| dc.date.accessioned | 2020-11-22T16:18:11Z | - |
| dc.date.available | 2020-11-22T16:18:11Z | - |
| dc.date.issued | 2020-10 | - |
| dc.identifier.uri | https://stiinta.usmf.md/ro/manifestari-stiintifice/zilele-universitatii | - |
| dc.identifier.uri | http://repository.usmf.md/handle/20.500.12710/13154 | - |
| dc.description | Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină și Farmacie „Nicolae Testemițanu” din Republica Moldova, Ziua internațională a științei pentru pace și dezvoltare | en_US |
| dc.description.abstract | Introduction:
• SARS-CoV-2 is a declared pandemic and health
threat.
• Previously identified SARS-CoV and MERS-CoV
from the same Betacoronavirus genus had
neurological implications.
Purpose:
To emphasize relationship between neurological
comorbidities and SARS-CoV-2 and management.
Material and methods:
A systematic review of PubMed and ResearchGate
articles using the mentioned keywords.
Results:
One-tenth of patients with existing neurological
comorbidities develop SARS-CoV-2.
Conclusions:
• Neurological comorbidities increased
susceptibility and presented in SARS-CoV-2.
• Differentiate existing comorbidities and SARS-CoV-2 to avoid misdiagnosis.
• Develop individualized plan to maintain
treatment and prevent exacerbation. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Universitatea de Stat de Medicină şi Farmacie "Nicolae Testemiţanu" | en_US |
| dc.subject | SARS-CoV-2 | en_US |
| dc.subject | coronavirus | en_US |
| dc.subject | neurology | en_US |
| dc.subject | comorbidities | en_US |
| dc.subject | 2019-nCoV | en_US |
| dc.title | Neurological comorbidities in patients with severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) | en_US |
| dc.type | Working Paper | en_US |
| Appears in Collections: | Culegere de postere
|
